Search research articles
Contact Us
Filters
Showing results (11-20 of 438) with videos related to
Page
of 44
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 1, 2025
Fifteen Years of PNPLA3: Transforming Hepatology Through Human Genetics
Stefano Romeo, Luca Valenti
Cell Cycle (Georgetown, Tex.)
|
April 5, 2014
CDKN1A: a double-edged sword in fatty liver?
Luca Valenti, Paola Dongiovanni
Hemodialysis International. International Symposium on Home Hemodialysis
|
March 16, 2017
HFE mutations and iron in hemodialysis patients
Luca Valenti, Serena Pelusi
Journal of Hepatology
|
April 3, 2026
From Human Genetics to Therapy: Targeting Alcohol and Steatotic Liver Disease via the FGF21 Liver-Brain Axis
Luca Valenti, Francesco Malvestiti
Journal of Hepatology
|
June 21, 2016
Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood
Luca Valenti, Stefano Romeo
International Journal of Molecular Sciences
|
March 22, 2016
Telomeres, NAFLD and Chronic Liver Disease
Benedetta Donati, Luca Valenti
Hepatology (Baltimore, Md.)
|
June 7, 2017
Mutant PNPLA3 I148M protein as pharmacological target for liver disease
Luca Valenti, Paola Dongiovanni
Blood Transfusion = Trasfusione Del Sangue
|
December 18, 2019
Uncovering occult hepatitis B in blood donations: a tale of two worlds
Daniele Prati, Luca Valenti
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 30, 2022
African genetic ancestry and protection against fatty liver disease
Stefano Romeo, Luca Valenti
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 15, 2022
Genetics: A new clinical tool for the hepatologist
Luca Valenti, Luisa Ronzoni
Page
of 44
Search research articles
Search
Showing results (11-20 of 438) with videos related to
Sort By:
Page
of 44
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 1, 2025
Fifteen Years of PNPLA3: Transforming Hepatology Through Human Genetics
Stefano Romeo, Luca Valenti
Cell Cycle (Georgetown, Tex.)
|
April 5, 2014
CDKN1A: a double-edged sword in fatty liver?
Luca Valenti, Paola Dongiovanni
Hemodialysis International. International Symposium on Home Hemodialysis
|
March 16, 2017
HFE mutations and iron in hemodialysis patients
Luca Valenti, Serena Pelusi
Journal of Hepatology
|
April 3, 2026
From Human Genetics to Therapy: Targeting Alcohol and Steatotic Liver Disease via the FGF21 Liver-Brain Axis
Luca Valenti, Francesco Malvestiti
Journal of Hepatology
|
June 21, 2016
Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood
Luca Valenti, Stefano Romeo
International Journal of Molecular Sciences
|
March 22, 2016
Telomeres, NAFLD and Chronic Liver Disease
Benedetta Donati, Luca Valenti
Hepatology (Baltimore, Md.)
|
June 7, 2017
Mutant PNPLA3 I148M protein as pharmacological target for liver disease
Luca Valenti, Paola Dongiovanni
Blood Transfusion = Trasfusione Del Sangue
|
December 18, 2019
Uncovering occult hepatitis B in blood donations: a tale of two worlds
Daniele Prati, Luca Valenti
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 30, 2022
African genetic ancestry and protection against fatty liver disease
Stefano Romeo, Luca Valenti
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 15, 2022
Genetics: A new clinical tool for the hepatologist
Luca Valenti, Luisa Ronzoni
Page
of 44